Total Payments
$6,596
2024 Payments
$901.77
Companies
36
Transactions
377
Medicare Patients
5,705
Medicare Billing
$190,458
Payment Breakdown by Category
Food & Beverage$6,558 (99.4%)
Education$37.33 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,558 | 374 | 99.4% |
| Education | $37.33 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,506 | 70 | $0 (2024) |
| ABBVIE INC. | $705.21 | 46 | $0 (2024) |
| Lilly USA, LLC | $518.20 | 29 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $438.17 | 25 | $0 (2024) |
| Amgen Inc. | $428.76 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $412.27 | 39 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $370.08 | 25 | $0 (2024) |
| PFIZER INC. | $332.32 | 21 | $0 (2024) |
| Amarin Pharma Inc. | $268.24 | 9 | $0 (2022) |
| Abbott Laboratories | $228.53 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $901.77 | 49 | Novo Nordisk Inc ($252.41) |
| 2023 | $1,459 | 84 | Novo Nordisk Inc ($492.19) |
| 2022 | $1,467 | 88 | Biohaven Pharmaceutical Holding Company Ltd. ($225.60) |
| 2021 | $629.90 | 38 | AbbVie Inc. ($232.23) |
| 2020 | $821.57 | 42 | Novo Nordisk Inc ($216.45) |
| 2019 | $960.01 | 59 | Novo Nordisk Inc ($342.70) |
| 2018 | $334.12 | 15 | Amarin Pharma Inc. ($126.72) |
| 2017 | $22.85 | 2 | PFIZER INC. ($11.87) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Hematology | ||||||
| 07/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Obesity | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.03 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Hematology | ||||||
| 06/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Cardio-renal | ||||||
| 06/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: VACCINES | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Obesity | ||||||
| 05/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: PAIN | ||||||
| 05/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Cardio-renal | ||||||
| 05/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: DIABETES | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Hematology | ||||||
| 04/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Obesity | ||||||
| 04/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardio-renal | ||||||
| 04/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 2,000 | 2,699 | $192,459 | $81,130 |
| 2022 | 32 | 1,563 | 2,098 | $130,712 | $51,392 |
| 2021 | 27 | 1,145 | 1,428 | $88,824 | $32,874 |
| 2020 | 23 | 997 | 1,312 | $77,227 | $25,062 |
Total Patients
5,705
Total Services
7,537
Medicare Billing
$190,458
Procedure Codes
119
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 163 | 255 | $38,760 | $18,190 | 46.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 65 | 65 | $15,795 | $9,821 | 62.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 26 | 26 | $8,580 | $7,345 | 85.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 59 | $12,095 | $6,362 | 52.6% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 26 | 32 | $11,264 | $4,473 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $9,553 | $3,915 | 41.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $6,132 | $3,356 | 54.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 55 | $5,665 | $3,138 | 55.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 217 | 370 | $7,034 | $3,090 | 43.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 39 | 39 | $5,401 | $2,802 | 51.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 161 | 207 | $11,799 | $2,716 | 23.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 176 | 247 | $9,376 | $2,556 | 27.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 204 | 308 | $10,472 | $2,315 | 22.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $3,634 | $1,502 | 41.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 41 | $1,476 | $1,166 | 79.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 58 | 69 | $5,037 | $1,136 | 22.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 31 | 36 | $4,140 | $1,044 | 25.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 82 | 106 | $6,890 | $999.60 | 14.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $910.00 | $739.44 | 81.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 52 | 89 | $3,115 | $715.37 | 23.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 29 | 29 | $1,299 | $473.76 | 36.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 107 | 133 | $2,660 | $453.53 | 17.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 25 | 28 | $1,792 | $413.84 | 23.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 23 | 23 | $713.00 | $389.16 | 54.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 21 | 25 | $1,450 | $334.00 | 23.0% |
About Dr. Tabitha Marek, M.D
Dr. Tabitha Marek, M.D is a Family Medicine healthcare provider based in Eden Prairie, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2014. The National Provider Identifier (NPI) number assigned to this provider is 1245644814.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tabitha Marek, M.D has received a total of $6,596 in payments from pharmaceutical and medical device companies, with $901.77 received in 2024. These payments were reported across 377 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,558).
As a Medicare-enrolled provider, Marek has provided services to 5,705 Medicare beneficiaries, totaling 7,537 services with total Medicare billing of $190,458. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Eden Prairie, MN
- Active Since 06/11/2014
- Last Updated 08/14/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1245644814
Products in Payments
- NURTEC ODT (Drug) $579.76
- Ozempic (Drug) $541.43
- Kerendia (Drug) $438.17
- JANUVIA (Drug) $355.69
- UBRELVY (Drug) $333.29
- TRULICITY (Drug) $276.22
- Vascepa (Drug) $268.24
- Wegovy (Drug) $259.88
- QULIPTA (Drug) $245.13
- FARXIGA (Drug) $165.57
- Prolia (Biological) $147.11
- Otezla (Drug) $146.25
- FREESTYLE LIBRE 2 (Device) $143.47
- Rybelsus (Drug) $138.63
- JARDIANCE (Drug) $123.89
- MOUNJARO (Drug) $110.15
- ACCRUFER (Drug) $105.64
- VRAYLAR (Drug) $98.33
- EVENITY (Biological) $86.77
- TRINTELLIX (Drug) $80.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Eden Prairie
Dheeraj Taranath, Do, DO
Family Medicine — Payments: $278.29
Family Medicine $278.29
Jill Sonnenberg, Md, MD
Family Medicine — Payments: $137.55
Family Medicine $137.55
Benjamin Chaska, M.d, M.D
Family Medicine — Payments: $83.84
Family Medicine $83.84
Dr. Christine Hamilton, D.o, D.O
Family Medicine — Payments: $67.31
Family Medicine $67.31
David Olson
Family Medicine — Payments: $66.05
Family Medicine $66.05
Jessica Fashant-Peterson, Cnp, CNP
Family Medicine — Payments: $54.28
Family Medicine $54.28